FDA issues warning on four asthma drugs

Written by Andrew Traub

February 19, 2010

The government is taking steps to curb use of some long-acting asthma drugs taken by millions, issuing safety restrictions to lower an uncommon but potentially life-threatening risk that asthma could worsen suddenly. The warnings cover the drugs Advair, Symbicort, Foradil and Serevent. The FDA said they should be used only by asthmatics who can’t control their disease with other drugs — and then only for the shortest time possible.

You May Also Like…

1 Comment

  1. Dallashealthinsurance

    Once you’ve been diagnosed with asthma, your doctor may prescribe more than one asthma medication to relieve asthma symptoms and control asthma for the long-term.

    Reply

Submit a Comment

Your email address will not be published. Required fields are marked *